Has Chaim Mandelbaum, MD received payments from drug or device companies?

Yes. Drug and device makers reported $17,523 in general payments to Chaim Mandelbaum, MD across 941 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Chaim Mandelbaum, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Chaim Mandelbaum, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Chaim Mandelbaum, MD

Public Health & General Preventive Medicine · New York, NYNPI 1215075908

Payments from drug & device makers

$17,523in general payments, 2019–2025

Across 941 payments — averaging $18.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
AbbVie$2K
Amgen$2K
Collegium Pharmaceutical, Inc.$2K
Nevro Corp.$1K
Scilex Pharmaceuticals Inc.$935
plus $7K from 47 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	209	$2,386
AbbVie(2 entities)	123	$2,273
Amgen(2 entities)	69	$1,578
Collegium Pharmaceutical, Inc.	109	$1,577
Nevro Corp.	31	$1,301
Scilex Pharmaceuticals Inc.	50	$935
Pfizer	29	$672
Medtronic(2 entities)	9	$652
MDD US Operations, LLC	16	$602
Azurity Pharmaceuticals, Inc.	25	$592
Daiichi Sankyo Inc.	48	$440
Boston Scientific	14	$414
Redhill Biopharma Inc.	23	$317
Teva Pharmaceuticals USA, Inc.	16	$275
Forte Bio-pharma LLC	13	$254
Hikma Pharmaceuticals USA	12	$213
Axsome Therapeutics, Inc.	4	$204
Biohaven Pharmaceuticals, Inc.	5	$199
Pacira Therapeutics, Inc.	5	$182
Merz North America, Inc.	1	$178
Biodelivery Sciences International, Inc.	11	$172
GRT US Holding, Inc.	3	$151
Eisai Inc.	15	$151
Merck	10	$149
Takeda Pharmaceuticals U.S.A., Inc.	8	$133
Sentynl Therapeutics, Inc.	9	$113
Arbor Pharmaceuticals, Inc.	7	$107
Abbott	2	$95
Biohaven Pharmaceutical Holding Company Ltd.	5	$95
Novartis	5	$81
Ipsen Biopharmaceuticals, Inc	4	$79
Vertex	3	$77
Zyla Life Sciences, Inc.	4	$70
USWM, LLC	5	$67
Virtus Pharmaceuticals LLC	4	$62
Bioventus LLC	3	$60
Vertical Pharmaceuticals, LLC	3	$56
Johnson & Johnson	4	$55
Fidia Pharma USA Inc.	2	$50
Valinor Pharma, LLC	2	$48
Averitas Pharma Inc.	1	$46
Lundbeck LLC	2	$45
Almatica Pharma LLC	3	$44
Tersera Therapeutics LLC	2	$36
Zimmer Biomet	1	$35
AstraZeneca	2	$35
Saluda Medical Americas, Inc.	1	$34
IBSA Pharma Inc.	2	$31
Lilly USA, LLC	2	$28
Orexo US, Inc.	2	$25
Pernix Therapeutics Holdings, Inc.	1	$18
Upsher-smith Laboratories LLC	1	$18
Shionogi Inc	1	$12

How this compares

$17,523 in reported general payments places this provider in the 90th percentile of 30 public health & general preventive medicine providers in New York.

See all public health & general preventive medicine providers in New York →

Medicare billing

Part B allowed, 2024

$818,008

Medicare patients

337

Services billed

32,766

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other public health & general preventive medicine in New York

Lori MoscaNew York$103K
Beverly WinikoffNew York$30K
Willard HauserNew York$5K
Kevin CahillNew York$241
Stacey Cantor-AdkinsNew York$70
Stephen FriedmanNew York$23
Eugenio MateoNew York$19
Allen FeldmanNew York$18
Elizabeth MilbankNew York$17
Robert EpsteinNyack$10K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →